Little humor (this is simultaneously a joke, yet not a joke
Little humor (this is simultaneously a joke, yet not a joke at all).
We may not get the exposure at the Drug Discovery and Therapy World Congress that you may all might be thinking. This presentation below will be at the same time as ours and I think it would be hard to pass up on.
Kevetrin has met its match.
CONFERENCE ABSTRACT (SESSION SPEAKER)
Hot Topics in Natural Products
A MIXTURE OF CAMEL MILK AND URINE SHOWS ANTICANCER PROPERTIES IN VITRO AND IN VIVO: AN EVIDENCE OF A TRADITIONAL ETHNOMEDICINE PRACTICE
Fatema Habeeb
Medical Laboratory Sciences, Kuwait University, Kuwait
Abstract
Abstract Background: Treatment with urine and milk mixture of she camel's is well known remedy in the Arabic peninsula. There are claims that the mixture of camel milk and urine can treat several diseases including cancer. Several in vitro studies had shown that either camel milk or urine can cause selective apoptosis in different cancer cell lines. However, no single clinical case was reported to either support or refute the claims. Objective: To investigate the possible anticancer properties of camel milk and urine in vitro and in vivo. Methods: Camel’s urine was mixed with camel’s milk at different ratios. Then, camel’s urine and milk mixture was incubated with Kelly, HCT-116 and TE-671 for different time intervals. After which, the viability was measured by viability analyzer (Vi CELL). Mononuclear cells were isolated from normal blood was used as normal cells. After which, the ratio that reduced the viability of cancer cells but not normal cells was used to treat pancreatic adenocarcinoma patient post chemotherapy. Results: Results had shown that camel’s urine and milk mixture has significantly lowered the number of viable cancer cells in the three cell lines without affecting normal mononuclear cells isolated from the blood. Furthermore, the size of pancreatic cancer was significantly reduced in size from 7 x 6 x 5 cm to 6.2 x 5.5 x 4.5 cm after 9 days of treatment. No significant anticancer effect was observed in the liver. Conclusion: The mixture of camel’s urine and milk can be a possible anticancer remedy that worth further research. Studying the active components in the mixture is currently under investigation.
Keywords: Camel, Milk, Urine, Anticancer, Natural products.
On another note, Scottsmith PM'd me that he was trying to get in the phase 1 to earn a few extra $$
2
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....
Continue Reading
JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...
Continue Reading
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...
Continue Reading
Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...
Continue Reading
Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...
Continue Reading
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....
Continue Reading
A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...
Continue Reading
ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...
Continue Reading
Top 5 Most Recently Viewed Articles
DENTSPLY SIRONA Inc. Faces Legal Challenges The law firm Kessler Topaz Meltzer & Check, LLP has informed investors about a securities class action lawsuit filed against DENTSPLY SIRONA Inc. (NASDAQ: XRAY). This lawsuit could have significant implications for investors who acquired DENTSPLY common stock between certain periods. Important Details for Investors Investors who...
Continue Reading
Innovative External Urine Collection System An inventive individual from Stanwood has developed a groundbreaking external urine collection system aimed at improving comfort and health outcomes. The new system, known as the PART TIME CARETAKER, is designed to replace traditional indwelling urinary catheters. The inventor emphasizes the importance of comfort and reducing...
Continue Reading
Understanding Recent Investment Trends in Apple Options Recent activity in the options market shows that wealthy investors are betting on a positive outlook for Apple (NASDAQ:AAPL). This is notable for retail traders who closely monitor market dynamics. Insights from Option Trading Data Publicly available options trading history reveals an intriguing landscape of...
Continue Reading
Irvine Welcomes New Dining Destination And there it is, a fresh dining oasis gearing up to turn some heads out in Irvine. The Centerview is about to get even spicier with Fat of the Land, a celebrated tapas joint from Robert Paetz, making its way from Santa Ana to redefine what it means to dine in style. The Appeal of a ‘Third Space’ We’re not just talking about...
Continue Reading
Key Announcement from Kaixin Holdings Kaixin Holdings, a prominent entity in the new energy vehicle sector, recently shared an important update regarding its financial structure. The company announced a share consolidation, which will take place at a ratio of 1-for-60. This consolidation is aimed at refining its capital structure and enhancing shareholder value. Details...
Continue Reading